Upstream Bio, Inc. (NASDAQ: UPB) — Healthcare · Share Price, Chart & Market Data
About: Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.30 (-3.13%)
UPBUpstream Bio, Inc.
Loading watchlist status…
Trade UPB now
Upstream Bio, Inc. share price
UPB price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:43 am GMT+0
UPB price performance
0.432%
5D
7.266%
1M
-65.645%
YTD
5.923%
1Y
UPB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:43 am GMT+0
UPB Market Signals